Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Correction: The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series.
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Large-scale production of human mesenchymal stem cells for clinical applications.
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.
Clinical neurophysiology of multiple sclerosis.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Established disease-modifying treatments in relapsing-remitting multiple sclerosis.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease.
Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.

Pages